Davis Capital Management
TNDM icon

Davis Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Davis Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$65 Hold
4
– – ﹤0.01% 1098
2026
Q2 		$60 Buy
+4
New +$70 ﹤0.01% 1174

Other funds holding TNDM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Paradice Investment Management
Paradice Investment Management Denver, Colorado $594M AUM 28.38% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Davis Capital Management's TNDM Position: Q3 2026 in Review

Davis Capital Management held its Tandem Diabetes Care (TNDM) position steady in Q3 2026 at 4 shares worth $65. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

Davis Capital Management first reported a position in TNDM in Q2 2026 and has held it in 2 quarters since. 203 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

  • Davis Capital Management held 4 shares of Tandem Diabetes Care worth $65 as of Q3 2026.
  • Davis Capital Management left its Tandem Diabetes Care share count unchanged in Q3 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #1098 holding.
  • Davis Capital Management first reported a position in Tandem Diabetes Care in Q2 2026 and has held it in 2 quarters since.
  • 203 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.